Antimicrobial Susceptibility Testing ofChlamydophila pneumoniae: Pilot Study for Alternative Methods that Address the Complex Chlamydial Life Cycle
preprint
OA: closed
Abstract
Conventional susceptibility testing of Chlamydophila pneumoniae does not account for the complex life cycle that takes place in an obligatory intracellular niche and involves multiple morphological forms. Some of these forms (elementary bodies and cryptic bodies) cause persistence and are not susceptible to antimicrobial agents. Therefore, we describe a pilot study for alternative methods of susceptibility testing of C. pneumoniae . These methods include delaying the addition of antimicrobial agents to cell cultures for 48 hours to allow the development of an established chlamydial infection as well as the use of reverse transcriptase quantitative PCR [RT-qPCR] to measure messenger RNA. Using these methods, susceptibility testing of an established infection in Hep2 cells was compared with conventional susceptibility testing of C. pneumoniae . Conventional antimicrobial susceptibility testing of C. pneumoniae results in MICs and MBCs that would suggest that recommended treatment regimens of 2 to 3 weeks of antibiotics such as doxycycline, clarithromycin, levofloxacin, and rifabutin would be sufficient. However, susceptibility testing using an established chlamydial infection in HEp2 cells reveals that none of these agents are as inhibitory and/or bactericidal as indicated by conventional methods. The resultsof this pilot study suggest that further evaluation of chlamydial susceptibility testing methods using established infection in cell cultures and RT-qPCR to measure messenger RNA are needed to optimize treatment recommendations for chronic C. pneumoniae infections.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (26)
- doi:10.1128/aac.32.2.257 via crossref
- doi:10.1128/aac.33.9.1634 via crossref
- doi:10.1128/aac.36.2.291 via crossref
- doi:10.1128/aac.38.9.1873 via crossref
- doi:10.1128/iai.72.4.1843-1855.2004 via crossref
- doi:10.1016/j.micinf.2011.03.004 via crossref
- doi:10.1093/clinids/14.1.178 via crossref
- doi:10.1016/j.femsim.2004.03.004 via crossref
- doi:10.1080/00365540512331336622 via crossref
- doi:10.1093/jac/37.4.677 via crossref
- doi:10.1128/aac.43.9.2311 via crossref
- doi:10.1093/jac/dkx454 via crossref
- doi:10.3109/00365549709011865 via crossref
- doi:10.1128/aac.47.2.636-642.2003 via crossref
- doi:10.1128/aac.49.5.1852-1856.2005 via crossref
- doi:10.1086/315599 via crossref
- doi:10.1128/iai.66.4.1370-1376.1998 via crossref
- doi:10.1093/jac/dkl224 via crossref
- doi:10.2165/00003088-199937050-00003 via crossref
- doi:10.1093/clinids/22.supplement_1.s15 via crossref
- doi:10.2165/00003088-199732020-00002 via crossref
- doi:10.1128/aac.43.9.2268 via crossref
- doi:10.1128/jcm.39.10.3721-3723.2001 via crossref
- doi:10.1128/aac.46.2.409-412.2002 via crossref
- doi:10.1002/978047129259.mc11b01s12 via crossref
- doi:10.1093/nar/29.9.e45 via crossref
Source provenance
- crossref
- last seen: 2026-05-27T01:00:11.792420+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-08-08T06:39:30.753600+00:00